Delayed Dosing of S-033188, a Novel Inhibitor of Influenza Virus Cap-dependent Endonuclease, Exhibited Significant Reduction of Viral Titer and Mortality in Mice Infected with Influenza A Virus

BACKGROUND: Both epidemic and pandemic influenza are major public health concerns, but current standard treatment limits its usage by 48 hours from onsets. Furthermore, no antiviral drug has been shown to definitively reduce serious complications, hospitalization, or mortality in a randomized clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukao, Keita, Ando, Yoshinori, Noshi, Takeshi, Kawai, Makoto, Yoshida, Ryu, Shishido, Takao, Naito, Akira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631482/
http://dx.doi.org/10.1093/ofid/ofx163.1210

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631482/
http://dx.doi.org/10.1093/ofid/ofx163.1210

Ejemplares similares